STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
IKT
(IKT)
IKT
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
Inhibikase Therapeutics, Inc.
(IKT)
$1.73
▼
-0.13 (-6.99%)
Chart
Share
Post on X
IKT
Inhibikase Therapeutics, Inc.
(IKT)
NASDAQ
$1.73
▼
-0.13 (-6.99%)
Chart Studio
Share
IKT
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$201.54M
-10.6%
P/E Ratio
-4.18
+49.0%
P/S Ratio
0.00
ROE
-27.91%
+3.8%
ROIC
-26.57%
+11.7%
FCF Yield
-13.79%
-62.3%
Debt/Equity
0.00
Current Ratio
21.70
-17.7%
Interest Coverage
0.00x
Per Share
Revenue/Share
$0.00
Net Income/Share
$-0.49
-23.7%
Operating CF/Share
$-0.28
-2.4%
Free CF/Share
$-0.28
-2.4%
Cash/Share
$1.82
+29.3%
Book Value/Share
$1.76
+28.6%
Tangible Book/Share
$1.76
+28.6%
Equity/Share
$1.76
+28.6%
Interest Debt/Share
$0.00
Valuation
Market Cap
$201.54M
-10.6%
Enterprise Value
$62.32M
-63.1%
P/E Ratio
-4.18
+49.0%
P/S Ratio
0.00
P/OCF Ratio
-7.25
+38.4%
P/FCF Ratio
-7.25
+38.4%
P/B Ratio
1.17
-50.9%
P/TB Ratio
1.17
-50.9%
EV/Sales
0.00
EV/EBITDA
-1.36
+77.9%
Profitability
Earnings Yield
-23.95%
-96.2%
FCF Yield
-13.79%
-62.3%
ROE
-27.91%
+3.8%
ROIC
-26.57%
+11.7%
Return on Tangible Assets
-26.63%
+4.6%
Capital Allocation
CapEx/OCF
-0.05%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.22
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
0.00
Debt/Assets
0.00
Net Debt/EBITDA
3.03
+47.9%
Current Ratio
21.70
-17.7%
Interest Coverage
0.00x
Income Quality
0.58
-17.2%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
6987 days
-46.7%
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.05x
+87.5%
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$1.73
+28.2%